Autopsy report · NCT01536418
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
Cause of deathNo reason given
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 1 year 11 months before it stopped.
- 255 participants enrolled.
- Results were posted on the registry 3 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Crohn's Disease
- Interventions
- GSK1605786A; GSK1605786A
- Participants
- 255
- Sites
- 227
- Countries
- Australia, Austria, Belgium, Bulgaria, Canada, Chile, Czechia, Denmark, Estonia, France, Germany, Greece and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.